WO2002018424A3 - Nucleic acids and polypeptides - Google Patents

Nucleic acids and polypeptides Download PDF

Info

Publication number
WO2002018424A3
WO2002018424A3 PCT/US2001/027093 US0127093W WO0218424A3 WO 2002018424 A3 WO2002018424 A3 WO 2002018424A3 US 0127093 W US0127093 W US 0127093W WO 0218424 A3 WO0218424 A3 WO 0218424A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
polypeptides
present
novel
polypeptide sequences
Prior art date
Application number
PCT/US2001/027093
Other languages
French (fr)
Other versions
WO2002018424A2 (en
WO2002018424A9 (en
Inventor
Y Tom Tang
Vinod Asundi
Ping Zhou
Aidong J Xue
Feiyan Ren
Jie Zhang
Jian-Rui Wang
Qing A Zhao
Dunrui Wang
Chenghua Liu
Radoje T Drmanac
Tom Wehrman
Original Assignee
Hyseq Inc
Y Tom Tang
Vinod Asundi
Ping Zhou
Aidong J Xue
Feiyan Ren
Jie Zhang
Jian-Rui Wang
Qing A Zhao
Dunrui Wang
Chenghua Liu
Radoje T Drmanac
Tom Wehrman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyseq Inc, Y Tom Tang, Vinod Asundi, Ping Zhou, Aidong J Xue, Feiyan Ren, Jie Zhang, Jian-Rui Wang, Qing A Zhao, Dunrui Wang, Chenghua Liu, Radoje T Drmanac, Tom Wehrman filed Critical Hyseq Inc
Priority to CA002421122A priority Critical patent/CA2421122A1/en
Priority to EP01972931A priority patent/EP1328636A2/en
Priority to AU2001292561A priority patent/AU2001292561A1/en
Priority to US10/363,616 priority patent/US20040044181A1/en
Publication of WO2002018424A2 publication Critical patent/WO2002018424A2/en
Publication of WO2002018424A3 publication Critical patent/WO2002018424A3/en
Publication of WO2002018424A9 publication Critical patent/WO2002018424A9/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention provides novel nucleic acids, novel polypeptide sequences encoded by these nucleic acids and uses thereof.
PCT/US2001/027093 2000-09-01 2001-08-31 Nucleic acids and polypeptides WO2002018424A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002421122A CA2421122A1 (en) 2000-09-01 2001-08-31 Novel nucleic acids and polypeptides
EP01972931A EP1328636A2 (en) 2000-09-01 2001-08-31 Nucleic acids and polypeptides
AU2001292561A AU2001292561A1 (en) 2000-09-01 2001-08-31 Nucleic acids and polypeptides
US10/363,616 US20040044181A1 (en) 2001-08-31 2001-08-31 Novel nucleic acids and polypeptides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65493500A 2000-09-01 2000-09-01
US09/654,935 2000-09-01

Publications (3)

Publication Number Publication Date
WO2002018424A2 WO2002018424A2 (en) 2002-03-07
WO2002018424A3 true WO2002018424A3 (en) 2003-05-15
WO2002018424A9 WO2002018424A9 (en) 2004-04-15

Family

ID=24626815

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/027093 WO2002018424A2 (en) 2000-09-01 2001-08-31 Nucleic acids and polypeptides

Country Status (4)

Country Link
EP (1) EP1328636A2 (en)
AU (1) AU2001292561A1 (en)
CA (1) CA2421122A1 (en)
WO (1) WO2002018424A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002018565A2 (en) * 2000-08-30 2002-03-07 Bayer Aktiengesellschaft Regulation of human protein phosphatase iic-like enzyme
GB0022670D0 (en) 2000-09-15 2000-11-01 Astrazeneca Ab Molecules
WO2002052016A2 (en) * 2000-12-26 2002-07-04 Bayer Aktiengesellschaft Regulation of human protein l-isoaspartate o-methyltransferase-like enzyme
US6913904B2 (en) * 2001-03-27 2005-07-05 Applera Corporation Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
CA2443123A1 (en) 2001-04-10 2002-10-24 Agensys, Inc. Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
EP1661998A3 (en) * 2001-06-04 2006-12-06 Curagen Corporation Antigenic polypeptides, antibodies binding thereto, nucleic acids encoding the antigens, and methods of use
EP1412746A4 (en) * 2001-07-12 2007-08-08 Exelixis Inc HADHs AS MODIFIERS OF THE P21 PATHWAY AND METHODS OF USE
JP2005514921A (en) 2001-11-09 2005-05-26 ダナ−ファーバー キャンサー インスティチュート インク PGC-1β, novel PGC-1 homologue and use thereof
JP2006515745A (en) * 2002-10-23 2006-06-08 エクセリクシス， インク． MAP2K6 as a branch morphogenesis modifier and method of use
GB0328928D0 (en) * 2003-12-12 2004-01-14 Cancer Rec Tech Ltd Materials and methods relating to cell cycle control
US7858323B2 (en) 2004-06-09 2010-12-28 The Regents Of The University Of Michigan Phage microarray profiling of the humoral response to disease
WO2006005584A1 (en) * 2004-07-12 2006-01-19 Geneprot Inc. Polypeptide species useful for the treatment of neurological disorders
WO2006092209A1 (en) * 2005-03-02 2006-09-08 Galapagos Nv Novel targets and compounds useful in the treatment of a cardiovascular disorder, dyslipidemia and atherosclerosis, and methods to identify such compounds
EP2069793B9 (en) 2006-08-29 2017-08-16 Oxford BioTherapeutics Ltd Identification of protein associated with hepatocellular carcinoma, glioblastoma and lung cancer
JP5816558B2 (en) 2009-03-05 2015-11-18 メダレックス・リミテッド・ライアビリティ・カンパニーＭｅｄａｒｅｘ， Ｌ．Ｌ．Ｃ． Fully human antibody specific for CADM1
WO2011116209A2 (en) 2010-03-17 2011-09-22 The Regents Of The University Of Michigan Using phage epitopes to profile the immune response
CA2917348A1 (en) 2013-07-11 2015-01-15 Moderna Therapeutics, Inc. Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053312A1 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053312A1 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 18 July 1996 (1996-07-18), HILLIER L. ET AL.: "zh48g06.r1 Soares_fetal_liver_spleen_1NFLS_S1 Homo sapiens cDNA clone IMAGE:415354 5' similar to PIR:S23352 S23352 gene unc-93 protein 1 - Caenorhabditis elegans [1] ;, mRNA sequence.", XP002214455, retrieved from EBI Database accession no. W92071 *
DATABASE EMBL [online] 19 January 1998 (1998-01-19), PHILIPPS, S:: "Human DNA sequence from clone 366N23 on chromosome 6q27. Contains two genes similar to consecutive parts of the C. elegans UNC-93 (protein 1, C46F11.1) gene, a KIAA0173 and Tubulin-Tyrosine Ligase LIKE gene, a Mitotic Feedback...", XP002214453, retrieved from EBI Database accession no. AL021331 *
DATABASE SWALL [online] 1 November 1998 (1998-11-01), PHILLIPS, S.: "DJ366N23.1 (Putative C. elegans UNC-93 (Protein 1, C46F11.1) like protein).", XP002214454, retrieved from EBI Database accession no. O75651 *

Also Published As

Publication number Publication date
AU2001292561A1 (en) 2002-03-13
EP1328636A2 (en) 2003-07-23
CA2421122A1 (en) 2002-03-07
WO2002018424A2 (en) 2002-03-07
WO2002018424A9 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
WO2001075067A3 (en) Novel nucleic acids and polypeptides
WO2001057188A3 (en) Novel nucleic acids and polypeptides
WO2001057190A3 (en) Novel nucleic acids and polypeptides
WO2002022660A3 (en) Novel nucleic acids and polypeptides
WO2001066689A3 (en) Novel nucleic acids and polypeptides
WO2002031111A3 (en) Novel nucleic acids and polypeptides
WO2001088088A3 (en) Novel nucleic acids and polypeptides
WO2002059260A3 (en) Nucleic acids and polypeptides
WO2003054152A3 (en) Novel nucleic acids and polypeptides
WO2003025148A3 (en) Novel nucleic acids and polypeptides
WO2002070539A3 (en) Novel nucleic acids and polypeptides
WO2003023013A3 (en) Novel nucleic acids and polypeptides
WO2002081731A3 (en) Novel nucleic acids and polypeptides
WO2001053312A8 (en) Novel nucleic acids and polypeptides
WO2001053455A3 (en) Novel nucleic acids and polypeptides
WO2004009834A3 (en) Novel nucleic acids and secreted polypeptides
WO2003029271A3 (en) Novel nucleic acids and polypeptides
WO2004080148A3 (en) Novel nucleic acids and polypeptides
WO2002018424A3 (en) Nucleic acids and polypeptides
WO2004087874A3 (en) Novel nucleic acids and polypeptides
WO2001079449A3 (en) Novel nucleic acids and polypeptides
WO2001002571A3 (en) An interleukin-1 receptor antagonist and uses thereof
WO2003080795A8 (en) Novel nucleic acids and secreted polypeptides
WO2001075068A3 (en) Secreted proteins and polynucleotides encoding them
WO2002044340A3 (en) Novel nucleic acids and polypeptides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2421122

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001972931

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10363616

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001972931

Country of ref document: EP

COP Corrected version of pamphlet

Free format text: PAGES 282, 283, CLAIMS, ADDED; DUE TO A SCANNING ERROR DURING THE TECHNICAL PREPARATIONS FOR INTERNATIONAL PUBLICATION, REPLACE ALL PAGES (INCLUDING FRONT PAGE) BY CORRECT PAGES (286 PAGES)

WWW Wipo information: withdrawn in national office

Ref document number: 2001972931

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP